Skin-ion

Manufacturer
WAKO Korea Corp
Effective date
2009-11-24
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:23:09

Label at a glance#

ProductSkin-ion
Active ingredientARBUTIN, ADENOSINE, GLYCERIN
Label structure4 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION


INGREDIENTS:

WATER, ARBUTIN, GLYCERIN, VITAMIN C, ADENOSINE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BOX LABELBOX LABEL


OTC - WHEN USING SECTION

DIRECTION OF USE:

1. Open cap fill water (liquid)

2. After 30 minutes, spray it

3. After use all, refill water (liquid)

DESCRIPTION SECTION


DESCRIPTION:

1. Whenever you want to feel freshed:

    The Skin-Ion delivers a fine mist of reduced water that refreshes and hydrates dry, thirsty skin.  Use several times a day to give yourself a revitalizing lift.  In winter, rescue skin from overhead, dry indoor air.          Skin-Ion's gentle mist will freshen your look without disturbing your makeup.  At the beach or  during sports, wash away perspiration and pollutants and restore skin to a natural and healthy pH.

2. Take Skin-Ion when you fly to avoid dry, dehydrated skin.  Skin-Ion is even gentle enough for expectant mothers and the delicate skin of young babies.  Simply mist the skin of your face, neck, arms and body     several fines a day.

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
GLYCERIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
49742-1001-12019-10-21C16284748780-1956f9ecf-dd85-621f-e053-dbdaa90a74ad6fc39322-244c-4f35-a983-c994ac17632a

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49742-1001-1Skin-ion40 mL in 1 CARTONSPRAY401

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49742-1001SKIN-ION (ARBUTIN, ADENOSINE, GLYCERIN) SPRAY [WAKO KOREA CORP]1Legacy NDC, 1 package rows20100101_6fc39322-244c-4f35-a983-c994ac17632a.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ADENOSINEACTIVE INGREDIENTK72T3FS5671
ARBUTINACTIVE INGREDIENTC5INA23HXF1
GLYCERINACTIVE INGREDIENTPDC6A3C0OX1
ADENOSINEACTIVE MOIETYK72T3FS5671
ARBUTINACTIVE MOIETYC5INA23HXF1
GLYCERINACTIVE MOIETYPDC6A3C0OX1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49742-100149742-1001-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
ARBUTINC5INA23HXFACTIB
ADENOSINEK72T3FS567ACTIB
GLYCERINPDC6A3C0OXACTIB

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8089b888-7b55-44ea-a12a-6ab827edf4e86fc39322-244c-4f35-a983-c994ac17632a2009-11-24Exact identifier
spl id: 8089b888-7b55-44ea-a12a-6ab827edf4e8
spl set id: 6fc39322-244c-4f35-a983-c994ac17632a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.